Furthermore, the beneficial outcomes of activation of the central ACE2-Ang (1–7)-MasR pathway in ischemic stroke could be explained both by increases in Ang 1–7 levels as well as reductions in Ang II levels [23]. This evidence concerns the gene ANGPT1 and ischemic stroke.